hela human cervix adenocarcinoma cells (ATCC)
Structured Review

Hela Human Cervix Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 16355 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cervix/HeLa/pmc13208969-159-13-21
Average 99 stars, based on 16355 article reviews
Images
1) Product Images from "Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from Raja porosa"
Article Title: Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from Raja porosa
Journal: Marine Drugs
doi: 10.3390/md24050181
Figure Legend Snippet: In vitro anticancer effect of PK01# ( A , C ) and PK02# ( B , D ) on HeLa, SAS, PANC-1, and A-172 cancer cell lines after a 24 h incubation. Cell viability was evaluated by MTT assay. Statistical analysis was performed with GraphPad Prism 9.0. All data are presented as mean ± S.E.M. Two-way ANOVA followed by Dunnett’s post hoc test revealed significant changes in the SAS, HeLa, PANC-1, and A-172 cells (* p < 0.05, ** p < 0.01, *** p < 0.001), as compared to those of control fibroblasts. IC 50 was not determined (maximum inhibition < 50% in MTT assay).
Techniques Used: In Vitro, Incubation, MTT Assay, Control, Inhibition
Figure Legend Snippet: Comparison of cytotoxic effects of PK01# and PK02# after a 24 h incubation against ( A ) HeLa, ( B ) SAS, ( C ) PANC-1, and ( D ) A-172 cancer cell lines. Two-way ANOVA followed by Bonferroni’s post hoc test revealed a significant difference (* p < 0.05, ** p < 0.01) between PK01# and PK02# in SAS and A-172 cancer cells. UT denotes untreated cancer cells.
Techniques Used: Comparison, Incubation

